Clinical Trial Update: Preoperative Levosimendan and Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating preoperative levosimendan in patients with heart failure undergoing hip fracture surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hip Fracture

Drugs mentioned

• Simdax (levosimendan)

Snippet

Sponsor: Sykehuset i Vestfold HF | Conditions: Heart Failure, Hip Fracture | Phase 4 | Status: WITHDRAWN